- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rxsight Inc (RXST)
Rxsight Inc stock price live, this page displays NASDAQ RXST stock exchange data. View the RXST premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Rxsight Inc real time stock price chart below.
What Is the Rxsight Inc Stock Price Today?
The Rxsight Inc stock price today is 5.410.
What Is the Stock Symbol for Rxsight Inc?
The stock ticker symbol for Rxsight Inc is RXST.
Is RXST the Same as $RXST?
$RXST is a common way to refer to the Rxsight Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Rxsight Inc Trade On?
Rxsight Inc is listed and trades on the NASDAQ stock exchange.
Is Rxsight Inc a Good Stock to Buy?
Determining whether Rxsight Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Rxsight Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RXST quote. (ISIN: US78349D1072)
What Is the Rxsight Inc Stock Price Today?
The Rxsight Inc stock price today is 5.410.
What Is the Stock Symbol for Rxsight Inc?
The stock ticker symbol for Rxsight Inc is RXST.
Is RXST the Same as $RXST?
$RXST is a common way to refer to the Rxsight Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Rxsight Inc Trade On?
Rxsight Inc is listed and trades on the NASDAQ stock exchange.
Is Rxsight Inc a Good Stock to Buy?
Determining whether Rxsight Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Rxsight Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RXST quote. (ISIN: US78349D1072)
5.410
+0.130(+2.46%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.040
5.491
52 wk Range
4.110
13.220
RXST is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.0405.491
52 wk Range
4.11013.220
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RXST Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
6.100
Upside
+12.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Rxsight receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Rxsight receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Rxsight receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
7 Hold
2 Sell
Ratings:
10 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 6.100
(+12.75% Upside)
Rxsight Inc Earnings Call Summary for Q3/2026
- RxSight Q3 revenue fell 19% YoY to $24.6M, missing $27.19M consensus; adjusted EPS of -$0.21 beat estimates but shares dropped 10.68% after-hours.
- LAL procedure volume declined 11% YoY to 23,128 units due to seasonality, competitive pressure, and internal sales force restructuring disruption.
- Gross margin compressed to 73.6% from 79.9% YoY on higher inventory reserves; company ended quarter with $254.7M cash including $60M Alcon upfront payment.
- Management expects Q4 LAL sales similar to Q2 levels, implying mid-to-high single-digit sequential growth; plans to reduce 2027 operating expenses.
- Next-generation adjustable lens targets 2028 approval at earliest; company focusing on rebuilding LAL utilization and executing Alcon collaboration.
Last Updated: 11/03/2026, 05:24 PM
Read Full TranscriptEarnings
Latest Release
Nov 03, 2026
EPS / Forecast
-0.21 / -0.29
Revenue / Forecast
24.6M / 27.19M
Compare RXST to Peers and Sector
Metrics to compare | RXST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRXSTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −1.5x | −0.2x | |
PEG Ratio | 0.09 | −0.35 | 0.00 | |
Price / Book | 0.9x | 2.5x | 2.6x | |
Price / LTM Sales | 1.9x | 3.3x | 2.8x | |
Upside (Analyst Target) | 12.1% | 15.1% | 60.5% | |
Fair Value Upside | Unlock | 3.7% | 7.8% | Unlock |
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company’s RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Rxsight (RXST) Stock Price Today?
The Rxsight stock price today is 5.410 USD.
What Stock Exchange Does Rxsight Trade On?
Rxsight is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Rxsight?
The stock symbol for Rxsight is "RXST."
What Is the Rxsight Market Cap?
As of today, Rxsight market cap is 225.580M USD.
What Is Rxsight's Earnings Per Share (TTM)?
The Rxsight EPS (TTM) is -1.29.
When Is the Next Rxsight Earnings Date?
Rxsight will release its next earnings report on Mar 03, 2027.
From a Technical Analysis Perspective, Is RXST a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Rxsight Stock Split?
Rxsight has split 0 times.
How Many Employees Does Rxsight Have?
Rxsight has 461 employees.
What is the current trading status of Rxsight (RXST)?
As of Nov 12, 2026, Rxsight (RXST) is trading at a price of 5.410 USD, with a previous close of 5.280 USD. The stock has fluctuated within a day range of 5.040 USD to 5.491 USD, while its 52-week range spans from 4.110 USD to 13.220 USD.
What Is Rxsight (RXST) Price Target According to Analysts?
The average 12-month price target for Rxsight is 6.100 USD, with a high estimate of 8 USD and a low estimate of 5 USD. 1 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +12.75% Upside potential.
What Is the RXST Premarket Price?
RXST's last pre-market stock price is 5.170 USD. The pre-market share volume is 829.000, and the stock has decreased by -0.110, or -2.080%.
What Is the RXST After Hours Price?
RXST's last after hours stock price is 5.210 USD, the stock has decreased by -0.070, or -1.330%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.